HomeTrading IdeasFTSE 100, DAX Forecast:...

FTSE 100, DAX Forecast: 2 Top Trades to Watch

rises to record highs, boosted by miners. hits record highs as investors await EU-US trade deal news.

FTSE Rises to Record Highs, Boosted by Miners

The FTSE 100 has risen to a record high, boosted by the mining sector, as investors react to Trump’s latest tariff announcement.

Anglo American has risen over 4%, whilst Rio Tinto (NYSE:) and Glencore (LON:) are trading over 3.5% higher following confirmation from President Trump that 50% tariffs will be applied to from August 1st.

The latest announcement on Truth Social has created volatility in the copper market, with the US copper price rising to record highs, as demand surges and importers rush to bring in copper before the start of the tariffs. The global copper prices on the London Metals Exchange have fallen, widening the gap between the two prices, suggesting that the market considers the longer-term impacts to be negative on copper prices. JP Morgan has supported this view, saying they expect copper prices to come under pressure as demand is expected to be met by two dislocated inventories.

There’s still little detail on how these tariffs will be implemented, but they would likely be considered severely inflationary. All of this increases the chances of more volatile trading across the commodities market in the coming days and for miners on the FTSE.

The UK economic calendar is quiet; attention will remain focused on Trump’s trade tariffs.

Trump has also threatened to impose high tariffs on the pharmaceutical industry, with potential threats of 200% tariffs on farm imports in the future, although there have been no concrete announcements.

FTSE 100 Forecast – Technical Analysis

The FTSE 100 broke out of its rising channel, pushing above 8910, the June high, and pushing to fresh record levels of 8950. Buyers will look to extend gains towards 9000 as the next logical target. The RSI is deeply oversold, so buyers should be cautious.

Support is at 8910. A break below here brings 8875, the upper band of the rising channel, into play, followed by 8850. A Break below here creates a lower low.

DAX Hits Record Highs as Investors Await EU-US Trade Deal News

The DAX, along with its European peers, is rising on Thursday as investors await a potential trade deal between the US and the EU and ahead of the start of the earnings season next week.

EU and US negotiators have moved closer to a deal. According to EU trade chief Sefcovic, good progress has been made on a framework agreement with Washington, with a deal potentially being announced within days. Negotiators are discussing measures to help protect the EU auto industry, including tariff cuts and import quotas. Despite uncertainty, European shares are performing well, with banks reaching multi-year highs.

Trump’s trade tariffs are in focus after the president announced a 50% tariff on copper imports and a 50% duty on goods from Brazil, both effective as of August 1st. He also issued seven new letters to training partners, adding to 14 issued earlier in the week, stating that new trading tariffs.

It appears that investors are becoming desensitized to the latest developments. U.S. stocks rose towards record levels, and Nvidia (NASDAQ:) briefly passed the $4 trillion market capitalization level, adding to the upbeat mood.

Moreover, tech stocks focused on after Taiwan Semiconductor Manufacturing (NYSE:), the world’s largest contract chipmaker, posted Q2 revenue above forecasts as demand for its products surged amid growing interest in advanced AI applications.

DAX Forecast – Technical Analysis

The DAX has extended its recovery from 23k, rising above 24,900, the previous all-time high, to reach fresh record levels at 24,650.

Buyers will look to extend the bullish trend towards 25,000.

Immediate support is at 24,490. Below here 24,000 comes into play. A break below 23k creates a lower low.

DAX Index-Daily Chart

Original Post

Most Popular

More from Author

Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study – Pfizer (NYSE:PFE)

Pfizer Inc. PFE and Astellas Pharma Inc. ALPMF ALPMY on Thursday...

The Powell-Trump Clash is Set to Escalate

Growth challenges are mounting while tariffs will lift inflation, but stagflation...

Why Is AbbVie Stock Trading Higher On Thursday? – AstraZeneca (NASDAQ:AZN), AbbVie (NYSE:ABBV)

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos...

Read Now

The Market Everyone Gave Up On Is Crushing Nasdaq 100 In 2025 – Global X MSCI Greece ETF (ARCA:GREK), Invesco QQQ Trust, Series 1...

Greece's 2010 collapse was so severe it leased islands, gutted public jobs and pensions, while some abroad even joked about selling the Acropolis to appease creditors.Fast forward 15 years, and the picture couldn't be more different.The Athens Stock Exchange has soared nearly 34% year-to-date, making Greece the...

Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study – Pfizer (NYSE:PFE)

Pfizer Inc. PFE and Astellas Pharma Inc. ALPMF ALPMY on Thursday released topline results from the overall survival (OS) analysis from the Phase 3 EMBARK study evaluating Xtandi (enzalutamide), in combination with leuprolide and as a monotherapy, in men with non-metastatic hormone-sensitive prostate cancer with biochemical recurrence...

The Powell-Trump Clash is Set to Escalate

Growth challenges are mounting while tariffs will lift inflation, but stagflation fears are wide of the mark. The Fed will likely delay rate cuts until the end of the year, despite escalating pressure from the president, but may move in larger steps when it does cutConsumer Caution...

Why Is AbbVie Stock Trading Higher On Thursday? – AstraZeneca (NASDAQ:AZN), AbbVie (NYSE:ABBV)

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation Inc., and AbbVie Inc. ABBV, on Thursday, announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001, developed using IGI’s proprietary BEAT protein platform, for oncology and autoimmune diseases.“Multispecifics including trispecific antibodies represent...

Dynamic Hedging and FX Risk Analysis Within Tactical Asset Allocation Rules

Often, investors fully hedge their portfolios for currency risk. This can lead to significant drag in performance for currencies with negative carry. However, not hedging the foreign currency exposure can lead to significant drawdowns, especially for conservative investments. In this paper, we consider a conservative, global tactical...

German CPI Confirmed at 2.0%, Euro Drifting, FOMC Split Over Cuts

The euro continues to have a quiet week and is drifting for a third consecutive day. In the European session, is trading at 1.1730, up 0.09% on the day.German Inflation Dips to 2% as food, Energy Prices FallGerman inflation rose 2.0% y/y in June, in line...

Klotho Stock Delivers 1,222% Biotech Blowout: Opportunity or Bubble? – Klotho Neurosciences (NASDAQ:KLTO)

Shares of Klotho Neurosciences, Inc. KLTO have soared more than 1000% over the past three months on promising results and breakthrough hopes. Klotho stock was in the spotlight again Thursday after announcing an FDA nod on its ALS treatment candidate. What's Driving The Rally: Klotho announced it has received...

Eurozone Economic Weakness Laid Bare as US Front-Loading Effects Wane

Eurozone data remains volatile amid trade war developments, but the underlying trend is still sluggish. Uncertainty is slowing domestic demand, which contributes to our expectation of a further rate cut from the European Central Bank in SeptemberEurozone Economy Shows Further Weakness in the Second QuarterThe eurozone economy...

SeaStar Medical’s QUELIMMUNE Wins Prestigious Award From The National Kidney Foundation, Former Winners Include Names Like Janssen, Merck and Otsuka – Johnson & Johnson...

When it comes to unmet needs in the nephrology space, acute kidney injury remains a significant concern. That's particularly true regarding pediatric AKI – each year, about 4,000 children with AKI require continuous renal replacement therapy (RRT), with a mortality rate of approximately 51-58%. Many of those...

Why Are Biotech Stocks Ultragenyx And Mereo Facing A Sell-Off? – Ultragenyx Pharmaceutical (NASDAQ:RARE), Mereo BioPharma Group (NASDAQ:MREO)

Ultragenyx Pharmaceutical Inc. RARE and Mereo BioPharma Group plc MREO stocks are plunging on Thursday.What Happened?The companies on Wednesday announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward...

3 Things to Watch This Week: Trade-War Worries, Earnings, and Record Highs

After the long holiday weekend, we’re back to a full week of trading. Here are a few things we’re watching for this week. First, trade-war headlines. The Trump Administration’s original deadline was July 9th, and while that date is still in focus for investors, it now appears that many...

The Energy Report: Peak Oil Demand

Just breaking… is discussing pausing their output production hikes from October, saying that we would not ever consume as much oil as we did in the past. As predicted the “Peak Demand” oil theory has been dis-proven again. The United Arab Emirates oil minister Suhail Al Mazroui said that...